Download PDF
Int J Angiol
DOI: 10.1055/a-2572-1026
Original Article

Outcome of Redo Endovascular Interventions in Cases of Infra-inguinal Arterial Occlusive Disease

Khaled Mohamed Fekry
1   Department of Vascular Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Sherif Balbaa
1   Department of Vascular Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Ahmed Saeed
1   Department of Vascular Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Ahmed Alaa Shaker
1   Department of Vascular Surgery, Faculty of Medicine, Cairo University, Cairo, Egypt
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Background

The aim was to assess the outcomes of different redo endovascular interventions in terms of wound healing and limb salvage within 6 months.

Materials and Methods

From April 2024 to October 2024, a prospective clinical study was carried out on 56 patients who presented with chronic limb-threatening ischemia (CLTI) after previous peripheral endovascular intervention 6 months to 1 year earlier.

Results

Regarding technical success, restored linear blood flow from common femoral artery (CFA) to foot was higher in stenting and drug-coated balloon (DCB) than plain old balloon angioplasty (POBA) (p value = 0.032 and 0.033 respectively). Restoration of pedal pulse was statistically higher in DCB than in stenting (p value = 0.006) and higher in stenting than POBA (p value = 0.003). Wound healing at time frame of 3 months after the operation was statistically higher in DCB than POBA and stenting (p value = 0.002 and 0.007 respectively) and higher in stenting than POPA (p value = 0.033). Regarding amputation-free survival, above ankle amputation within 6 months of follow-up was lower in stenting and DCB than POBA (p value = 0.016 and 0.018 respectively) and there was no statistical difference between stenting and DCB (p value = 0.166).

Conclusion

Stenting and DCBs have demonstrated a superior ability than POBA to restore linear blood flow from the CFA to the foot, leading to better amputation-free survival rates, including a decreased likelihood of above ankle amputation within the first 6 months of follow-up. When it comes to wound healing and sustaining limb-based patency, DCB angioplasty has shown better performance compared with stenting and POBA.

Keywords

redo - endovascular - angioplasty - infra-inguinal - CLTI - DCB - POPA

Authors' Contributions

A.S. was involved in writing, data collection, and revision of the manuscript. A.S. and K.M.F. contributed to the revision and writing, while S.B. also participated in the revision and writing process. All authors read and approved the final version of the manuscript.


Ethical Approval

The study was approved by the ethics committee of Faculty of Medicine, Cairo University, Egypt.


Patients' Consent

An informed consent was obtained from each patient. There are adequate provisions to maintain privacy of the participants and confidentiality of the data. The patients were given the option of not participating in the study if they did not want to. All the data of the patients were kept confidential with secret codes and private file for each patient; all given data were used for current medical research only. Any unexpected risks that appeared during the research were cleared to the participants and the ethics committee on time.




Publication History

Article published online:
07 May 2025

© 2025. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Alexandrescu VA, Hubermont G, Philips Y. et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther 2008; 15 (05) 580-593
    PubMedSearch in Google Scholar
  • 2 Anderson JL, Halperin JL, Albert NM. et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127 (13) 1425-1443
    PubMedSearch in Google Scholar
  • 3 Conte MS, Bradbury AW, Kolh P. et al; GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS). Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019; 58 (1S): S1-S109.e33
    CrossrefPubMedSearch in Google Scholar
  • 4 Halvorsen S, Mehilli J, Cassese S. et al; ESC Scientific Document Group. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022; 43 (39) 3826-3924
    CrossrefPubMedSearch in Google Scholar
  • 5 Fowkes FG, Rudan D, Rudan I. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382 (9901) 1329-1340
    CrossrefPubMedSearch in Google Scholar
  • 6 Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol 2004; 15 (11) 1197-1207
    PubMedSearch in Google Scholar
  • 7 Byskosh N, Pamulapati V, Xu S. et al. Identifying gaps in disease knowledge among patients with peripheral artery disease. J Vasc Surg 2022; 75 (04) 1358-1368.e5
    PubMedSearch in Google Scholar
  • 8 Ramakrishnan D, de Virgilio C. Right calf pain with walking. In: de Virgilio C, Grigorian A. eds. Surgery: A Case Based Clinical Review. Cham: Springer International Publishing; 2020: 635-643
    Search in Google Scholar
  • 9 Dakhel A, Zarrouk M, Ekelund J. et al. Worse cardiovascular prognosis after endovascular surgery for intermittent claudication caused by infrainguinal atherosclerotic disease in patients with diabetes. Ther Adv Endocrinol Metab 2020; 11: 2042018820960294
    CrossrefPubMedSearch in Google Scholar
  • 10 Shammas NW, Lam R, Mustapha J. et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 2012; 19 (04) 480-488
    CrossrefPubMedSearch in Google Scholar
  • 11 Nur Rosyid F. Etiology, pathophysiology, diagnosis and management of diabetics' foot ulcer. Int J Res Med Sci 2017; 5: 42-56
    PubMedSearch in Google Scholar
  • 12 Klein AJ, Jaff MR, Gray BH. et al. SCAI appropriate use criteria for peripheral arterial interventions: an update. Catheter Cardiovasc Interv 2017; 90 (04) E90-E110
    CrossrefPubMedSearch in Google Scholar
  • 13 Goodney PP, Holman K, Henke PK. et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg 2013; 57 (06) 1471-1479 , 1480.e1–1480.e3, discussion 1479–1480
    PubMedSearch in Google Scholar
  • 14 Sun G, Liu J, Jia S. et al; AcoArt I Trial Investigators. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: an additional analysis from the AcoArt I study. Vascular 2021; 29 (03) 340-349
    PubMedSearch in Google Scholar
  • 15 Nugteren MJ, Welling RHA, Bakker OJ, Ünlü Ç, Hazenberg CEVB. Vessel preparation in infrapopliteal arterial disease: a systematic review and meta-analysis. J Endovasc Ther 2024; 31 (02) 191-202
    PubMedSearch in Google Scholar
  • 16 Bettink S, Löchel M, Peters D, Haider W, Speck U, Scheller B. Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model. Int J Cardiol 2021; 331: 46-56
    PubMedSearch in Google Scholar
  • 17 Abdelrady M, Rodriguez J, Dargazanli C. et al; PICASO (Reperfusion in Intracranial Atherosclerosis-related Occlusions) Investigators Group. Angioplasty, stenting, or both—rescue maneuvers and reperfusion after endovascular therapy for intracranial atherosclerosis-related occlusion. Neuroradiology 2023; 65 (04) 775-784
    PubMedSearch in Google Scholar
  • 18 Rykowska I, Nowak I, Nowak R. Drug-eluting stents and balloons—materials, structure designs, and coating techniques: a review. Molecules 2020; 25 (20) 4624
    PubMedSearch in Google Scholar
  • 19 Katib N, Varcoe RL. Intervention for chronic lower. In: Loftus I, Hinchliffe RJ. eds. Vascular and Endovascular Surgery. Elsevier Health Sciences; 2023: 39-57
    Search in Google Scholar
  • 20 Guo J, Ye M, Zhang W. et al. Early outcomes of drug-coated balloon angioplasty of infrapopliteal lesions in diabetic foot. Vasc Investig Ther 2024; 7 (01) 1-6
    PubMedSearch in Google Scholar
  • 21 Caradu C, Lakhlifi E, Colacchio EC. et al. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg 2019; 70 (03) 981-995.e10
    CrossrefPubMedSearch in Google Scholar
  • 22 Morgan III JH, Wall Jr CE, Christie DB, Harvey RL, Solis MM. The results of superficial femoral, popliteal, and tibial artery stenting for peripheral vascular occlusive disease. Am Surg 2005; 71 (11) 905-909 , discussion 909–910
    PubMedSearch in Google Scholar
  • 23 Marmagkiolis K, Hakeem A, Choksi N. et al. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Catheter Cardiovasc Interv 2014; 84 (04) 555-564
    PubMedSearch in Google Scholar
  • 24 Rocha-Singh KJ, Beckman JA, Ansel G. et al; VIVA Physicians, Inc. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation. Catheter Cardiovasc Interv 2017; 89 (07) 1250-1256
    PubMedSearch in Google Scholar
  • 25 Al Halabi S, Templeton E, Heaney C. et al. Drug-coated versus uncoated percutaneous transluminal angioplasty balloons for the treatment of infrapopliteal peripheral artery disease: a systematic review and meta-analysis of randomized controlled trials. J Crit Limb Ischemia 2022; 2 (01) E11-E16
    PubMedSearch in Google Scholar
  • 26 Hata Y, Iida O, Ito N. et al. Roles of angioplasty with drug-coated balloon for chronic ischemia in wound healing. J Endovasc Ther 2021; 28 (05) 778-787
    PubMedSearch in Google Scholar
  • 27 Hashish IMA, Ghareeb OH, Salem AAE. Evaluation of role of endovascular intervention in treatment of patients with critical lower limb ischemia. Zagazig Univ Med J 2021; 27 (04) 655-663
    PubMedSearch in Google Scholar
  • 28 Sallustro M, Peluso A, Turchino D. et al. Results of new dual-drug coated balloon angioplasty versus POBA for femoropopliteal lesions. Ann Vasc Surg 2023; 89: 52-59
    PubMedSearch in Google Scholar
  • 29 Hata Y, Iida O, Ito N. et al. Roles of angioplasty with drug-coated balloon for chronic ischemia in wound healing. J Endovasc Ther 2021; 28 (05) 778-787
    PubMedSearch in Google Scholar
  • 30 Anantha-Narayanan M, Shah SM, Jelani Q-U-A. et al. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: an updated meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv 2019; 94 (01) 139-148
    CrossrefPubMedSearch in Google Scholar